子宮頸抹片檢查的全球市場:現狀分析與預測(2022年～2028年)

Pap Test Market: Current Analysis and Forecast (2022-2028)

出版日期: 2023年02月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 159 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球子宮頸抹片檢查市場，由於子宮頸癌症患者的劇增，技術開拓，癌症診察計劃增加，預計穩定成長約11.4％。在全球子宮頸癌症劇增，成為促進該市場成長的主要原因。

本報告提供全球子宮頸抹片檢查市場相關調查分析，市場概要，各市場區隔、各地區的市場分析，市場成長的影響因素，市場趨勢，競爭情形，主要企業簡介等彙整資訊。

The human papillomavirus (HPV) family is made up of 150 or so closely related viruses. The human papillomavirus is divided into different types and numbers. Only particular cell types known as squamous epithelial cells are attracted to the human papillomavirus, and these cells are also the only ones where the virus can thrive. An accurate screening method to ascertain if cervical cells are abnormal or normal is the pap test. Commonly known as a pap smear is a treatment used to check women for cervical cancers. A pap smear can also identify alterations in cervical cells that point to the potential emergence of cancer. People who have abnormal pap test results are encouraged to get a human papillomavirus test to further assess their risk of cervical cancer.

The Pap Test Market is expected to grow at a steady rate of around 11.4% owing to a surge in the cases of cervical cancers, technological developments taking place, and a rise in the number of cancer screening programs. The surge in the prevalence of cervical cancers among the global population is the major factor responsible for thriving the growth of the market. For instance, according to the World Health Organization, 2021, cervical cancer is the world's fourth-most common cancer, with more than 500,000 cases diagnosed every year.

Based on the method, the market is segmented into liquid-based and conventional-based. The liquid-based segment held a dominant share of the market in 2021. The major reason for the growth in this segment is attributed to the advantages that are offered by these methods. Liquid-based methods have been developed to improve the diagnostic reliability of Papanicolaou (Pap) smears. Traditional methods such as conventional pap smears used to have false-negative and false-positive results owing to inefficient sampling and slide preparation, and errors in laboratory detection and interpretation. Liquid-based methods rinse cervical cells in preservatives so that blood and other potentially obscuring material can be easily separated. It also allows for additional testing of the sample, such as HPV, leading to the growth of the pap test market.

On the basis of application, the market is segmented into cervical cancer screening, vaginal cancer screening, and others. The cervical cancer screening category is expected to hold a major market share during the forecast period owing to the rise in the number of cases of cervical cancers worldwide and the rising need for their diagnosis using pap tests. Moreover, rising initiatives and accurate screening programs are now being implemented so that every woman with cervical disease gets the treatment she needs. WHO's global strategy for cervical cancer elimination- endorsed by the World Health Assembly in 2020 - requires 70% of women globally to be screened regularly for cervical disease with a high-performance test, and 90% of those needing it to receive appropriate treatment. Thus, the above-mentioned factors are the significant factor driving the segmental growth during the forecast period.

On the basis of technology, the market is bifurcated into PCR and others. The others held a dominant share of the market in 2021. The others segment consists of colposcopy and ELISA techniques among others. The dominant share is mainly due to the high adoption rate for colposcopy examinations done for the determination of cervical cancers.

For a better understanding of the market adoption of the pap test, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to dominate the global pap test market mainly due to a surge in the cases of cervical cancers, leading to the need for rising awareness related to early screening for cancers, and various initiatives brought in during the forecast period. For instance, in 2020, WHO launched the Global Strategy to Accelerate the Elimination of Cervical Cancer, which outlined three key steps: vaccination, screening, and treatment. Successful implementation of all three reduced more than 40% of new cases of the disease and 5 million related deaths by 2050. Thus, these factors are driving the regional market in the forecast period.

Some of the major players operating in the market include: Abbott, F. Hoffmann-La Roche Ltd., BD, QIAGEN, Thermo Fisher Scientific Inc., HOLOGIC, INC., Seegene Inc., Arbor Vita Corporation, Femasys Inc., Hospital Equipment Mfg. Co., among others.

1 MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Pap Test Market
2.2. Research Methodology of the Pap Test Market
2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE PAP TEST MARKET

6 PAP TEST MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY METHOD

7.1. Liquid-based
7.2. Conventional-based

8 MARKET INSIGHTS BY TEST TYPE

8.1. Pap Smear
8.2. Primary HPV Screening
8.3. Co-Testing
8.4. Follow-Up Test for HPV

9 MARKET INSIGHTS BY APPLICATION

9.1. Cervical Cancer Screening
9.2. Vaginal Cancer Screening
9.3. Others

10 MARKET INSIGHTS BY PRODUCT

10.1. Instruments
10.2. Consumables
10.3. Others

11 MARKET INSIGHTS BY TECHNOLOGY

11.1. PCR
11.2. Others

12 MARKET INSIGHTS BY END-USER

12.1. Research Laboratories
12.2. Diagnostic Centers
12.3. Hospitals & Clinics
12.4. Others

13 MARKET INSIGHTS BY REGION

13.1. North America
- 13.1.1. U.S.
- 13.1.2. Canada
- 13.1.3. Rest of North America
13.2. Europe
- 13.2.1. Germany
- 13.2.2. U.K.
- 13.2.3. France
- 13.2.4. Italy
- 13.2.5. Spain
- 13.2.6. Rest of Europe
13.3. Asia-Pacific
- 13.3.1. China
- 13.3.2. Japan
- 13.3.3. India
- 13.3.4. Rest of Asia-Pacific
13.4. Rest of World